ArticleHepatology (Baltimore, Md.)2014

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.

Arihiro Aihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.